Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2021-07-01 Sale | 2021-07-06 6:01 pm | Harpoon Therapeutics Inc. | HARP | Wesche Holger Chief Scientific Officer | 10,000 | $14 | $140,000 | 73,854 (Direct) | View |
2021-04-01 Sale | 2021-04-05 5:00 pm | Harpoon Therapeutics Inc. | HARP | Wesche Holger Chief Scientific Officer | 10,000 | $20.45 | $204,491 | 86,394 (Direct) | View |
2021-01-04 Sale | 2021-01-06 6:25 pm | Harpoon Therapeutics Inc. | HARP | Wesche Holger Chief Scientific Officer | 10,000 | $18.38 | $183,837 | 63,858 (Direct) | View |
2020-10-01 Sale | 2020-10-05 4:25 pm | Harpoon Therapeutics Inc. | HARP | Wesche Holger Chief Scientific Officer | 10,000 | $16.27 | $162,737 | 73,675 (Direct) | View |
2020-07-01 Sale | 2020-07-02 7:18 pm | Harpoon Therapeutics Inc. | HARP | Wesche Holger Chief Scientific Officer | 10,000 | $16.2 | $161,989 | 83,675 (Direct) | View |
2020-05-12 Sale | 2020-05-13 8:45 pm | Harpoon Therapeutics Inc. | HARP | Wesche Holger Chief Scientific Officer | 1,400 | $14.09 | $19,720 | 93,675 (Direct) | View |
2020-05-07 Sale | 2020-05-11 9:37 pm | Harpoon Therapeutics Inc. | HARP | Wesche Holger Chief Scientific Officer | 7,350 | $14.1 | $103,641 | 182,887 (Direct) | View |
2020-04-28 Sale | 2020-04-30 4:58 pm | Harpoon Therapeutics Inc. | HARP | Wesche Holger Chief Scientific Officer | 1,250 | $14.05 | $17,565 | 102,425 (Direct) | View |
2020-01-02 Sale | 2020-01-06 9:55 pm | Harpoon Therapeutics Inc. | HARP | Wesche Holger Chief Scientific Officer | 10,000 | $14.4 | $143,987 | 103,675 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2022-01-28 Option Award | 2022-02-01 4:09 pm | N/A 2032-01-27 | Harpoon Therapeutics Inc. | HARP | Wesche Holger Chief Scientific Officer | 135,000 | $0 | 135,000 (Direct) | View |
2021-11-11 Option Award | 2021-11-15 4:04 pm | N/A 2031-11-11 | Harpoon Therapeutics Inc. | HARP | Wesche Holger Chief Scientific Officer | 135,000 | $0 | 135,000 (Direct) | View |
2021-07-01 Exercise | 2021-07-06 6:01 pm | N/A N/A | Harpoon Therapeutics Inc. | HARP | Wesche Holger Chief Scientific Officer | 10,000 | $0.6 | 73,854 (Direct) | View |
2021-07-01 Exercise | 2021-07-06 6:01 pm | N/A 2026-04-06 | Harpoon Therapeutics Inc. | HARP | Wesche Holger Chief Scientific Officer | 10,000 | $0 | 73,854 (Direct) | View |
2021-04-01 Exercise | 2021-04-05 5:00 pm | N/A N/A | Harpoon Therapeutics Inc. | HARP | Wesche Holger Chief Scientific Officer | 10,000 | $0.6 | 86,394 (Direct) | View |
2021-04-01 Exercise | 2021-04-05 5:00 pm | N/A 2027-01-13 | Harpoon Therapeutics Inc. | HARP | Wesche Holger Chief Scientific Officer | 10,000 | $0 | 86,394 (Direct) | View |
2021-01-28 Option Award | 2021-01-29 8:02 pm | N/A 2031-01-27 | Harpoon Therapeutics Inc. | HARP | Wesche Holger Chief Scientific Officer | 52,000 | $0 | 52,000 (Direct) | View |
2021-01-04 Exercise | 2021-01-06 6:25 pm | N/A N/A | Harpoon Therapeutics Inc. | HARP | Wesche Holger Chief Scientific Officer | 10,000 | $0.6 | 63,858 (Direct) | View |
2021-01-04 Exercise | 2021-01-06 6:25 pm | N/A 2027-01-13 | Harpoon Therapeutics Inc. | HARP | Wesche Holger Chief Scientific Officer | 10,000 | $0 | 63,858 (Direct) | View |
2020-10-01 Exercise | 2020-10-05 4:25 pm | N/A N/A | Harpoon Therapeutics Inc. | HARP | Wesche Holger Chief Scientific Officer | 10,000 | $0.6 | 73,675 (Direct) | View |
2020-10-01 Exercise | 2020-10-05 4:25 pm | N/A 2027-01-13 | Harpoon Therapeutics Inc. | HARP | Wesche Holger Chief Scientific Officer | 10,000 | $0 | 73,675 (Direct) | View |
2020-07-01 Exercise | 2020-07-02 7:18 pm | N/A N/A | Harpoon Therapeutics Inc. | HARP | Wesche Holger Chief Scientific Officer | 10,000 | $0.6 | 83,675 (Direct) | View |
2020-07-01 Exercise | 2020-07-02 7:18 pm | N/A 2027-01-13 | Harpoon Therapeutics Inc. | HARP | Wesche Holger Chief Scientific Officer | 10,000 | $0 | 83,675 (Direct) | View |
2020-05-12 Exercise | 2020-05-13 8:45 pm | N/A N/A | Harpoon Therapeutics Inc. | HARP | Wesche Holger Chief Scientific Officer | 1,400 | $0.6 | 93,675 (Direct) | View |
2020-05-12 Exercise | 2020-05-13 8:45 pm | N/A 2027-01-13 | Harpoon Therapeutics Inc. | HARP | Wesche Holger Chief Scientific Officer | 1,400 | $0 | 93,675 (Direct) | View |
2020-05-07 Exercise | 2020-05-11 9:37 pm | N/A N/A | Harpoon Therapeutics Inc. | HARP | Wesche Holger Chief Scientific Officer | 7,350 | $0.6 | 182,887 (Direct) | View |
2020-05-07 Exercise | 2020-05-11 9:37 pm | N/A 2027-01-13 | Harpoon Therapeutics Inc. | HARP | Wesche Holger Chief Scientific Officer | 7,350 | $0 | 182,887 (Direct) | View |
2020-04-28 Exercise | 2020-04-30 4:58 pm | N/A N/A | Harpoon Therapeutics Inc. | HARP | Wesche Holger Chief Scientific Officer | 1,250 | $0.6 | 102,425 (Direct) | View |
2020-04-28 Exercise | 2020-04-30 4:58 pm | N/A 2027-01-13 | Harpoon Therapeutics Inc. | HARP | Wesche Holger Chief Scientific Officer | 1,250 | $0 | 102,425 (Direct) | View |
2020-01-31 Option Award | 2020-02-04 8:15 pm | N/A 2030-01-30 | Harpoon Therapeutics Inc. | HARP | Wesche Holger Chief Scientific Officer | 52,313 | $0 | 52,313 (Direct) | View |
2020-01-02 Exercise | 2020-01-06 9:55 pm | N/A N/A | Harpoon Therapeutics Inc. | HARP | Wesche Holger Chief Scientific Officer | 10,000 | $0.6 | 103,675 (Direct) | View |
2020-01-02 Exercise | 2020-01-06 9:55 pm | N/A 2027-01-13 | Harpoon Therapeutics Inc. | HARP | Wesche Holger Chief Scientific Officer | 10,000 | $0 | 103,675 (Direct) | View |